Showing results (81-90 of 139) with videos related to
Sort By:
Pageof 14
Gastroenterology|March 26, 2013
Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell typesÁgnes Holczbauer, Valentina M Factor, Jesper B Andersen, et al.Nature Communications|January 12, 2020
Dual-initiation promoters with intertwined canonical and TCT/TOP transcription start sites diversify transcript processingChirag Nepal, Yavor Hadzhiev, Piotr Balwierz, et al.Gut|September 27, 2023
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapyColm J O'Rourke, Massimiliano Salati, Colin Rae, et al.Journal of Hepatology|February 12, 2014
Sequential transcriptome analysis of human liver cancer indicates late stage acquisition of malignant traitsJens U Marquardt, Daekwan Seo, Jesper B Andersen, et al.Human Pathology|July 7, 2024
TPPP-BRD9 fusion-related gallbladder carcinomas are frequently associated with intracholecystic neoplasia, neuroendocrine carcinoma, and a distinctive small tubular-type adenocarcinoma commonly accompanied with a syringomatous patternBurcin Pehlivanoglu, Juan Carlos Araya, Scott Lawrence, et al.Oncogenesis|October 24, 2019
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cellsGiovanni Di Maira, Alessandra Gentilini, Mirella Pastore, et al.Molecular Cancer Therapeutics|December 17, 2008
UBE1L causes lung cancer growth suppression by targeting cyclin D1Qing Feng, David Sekula, Yongli Guo, et al.Gastroenterology|December 20, 2011
Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitorsJesper B Andersen, Bart Spee, Boris R Blechacz, et al.Journal of Hepatology|March 3, 2023
Liquid biopsy-based protein biomarkers for risk prediction, early diagnosis, and prognostication of cholangiocarcinomaAinhoa Lapitz, Mikel Azkargorta, Piotr Milkiewicz, et al.Journal of Cancer|March 5, 2020
Therapeutic Rationale to Target Highly Expressed Aurora kinase A Conferring Poor Prognosis in CholangiocarcinomaXiwei Ding, Tianlu Huang, Chunyan Peng, et al.Pageof 14